Description
Retatrutide is an investigational once-weekly TRIPLE hormone receptor agonist. Retatrutide is a single molecule that activates the body’s receptors for glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon.
**THIS PEPTIDE IS NOT YET APPROVED BY THE FDA AND IS FOR RESEARCH PURPOSES ONLY**


Reviews
There are no reviews yet.